🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
Multiple myeloma (MM) is the second most common hematologic malignancy with...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-02
Trial ID
NCT06050512
Treatments Being Tested
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Terminated
Location
Multiple Locations
Start Date
2012-06-05
Trial ID
NCT04272775
Treatments Being Tested
This is a Phase I/II trial of the combination pegylated IFN-alpha 2b with i...
Status
Terminated
Location
Fox Chase Cancer Center
Start Date
2015-08-14
Trial ID
NCT02447887
Treatments Being Tested
The main purpose of this study is to establish a safe and tolerable dose co...
Status
Withdrawn
Location
Columbia University Medical Center
Start Date
2020-11
Trial ID
NCT03880123
The study is designed as a multicenter, non-randomized, Phase II trial with...
Status
Completed
Location
Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik
Start Date
2018-09-20
Trial ID
NCT03731832
Treatments Being Tested
This is a phase I/II study of MLN9708 for the prophylaxis of chronic graft-...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2014-11-19
Trial ID
NCT02250300
Treatments Being Tested
This study will include participants with previously treated systemic relap...
Status
Completed
Location
Tufts Medical Center
Start Date
2011-04-27
Trial ID
NCT01318902
Treatments Being Tested
The purpose of this study is to evaluate the effect of Ixazomib on inducing...
Status
Completed
Location
University of Arkansas for Medical Science
Start Date
2015-09
Trial ID
NCT02499081
Treatments Being Tested
A Phase IB/II Trial of Lenalidomide (Revlimid®), Ixazomib and Rituximab (RI...
Status
Terminated
Location
University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-02-20
Trial ID
NCT02898259
Treatments Being Tested